TSLP Receptor, human, recombinant Reference: C-63771 Recombinant Human Thymic Stromal Lymphopoietin Receptor
LPA3 Blocking Peptide Reference: 10005092-200 Peptide Sequence: murine amino acids 1-12 (MNECHYDKRMDF) · To be used in conjunction with Cayman’s LPA3 polyclonal antibody (Item No. 10004840) to block protein-antibody complex formation during immunochemical analysis of ChREBP.
GPX4 Blocking Peptide Reference: 10005256-200 Peptide Sequence: Human GPX4 amino acids 81-93 · To be used in conjunction with Cayman’s GPX4 Polyclonal Antibody (Item No.10005258) to block protein-antibody complex formation during analysis for GPX4
Prostaglandin I Synthase (mouse) Blocking Peptide Reference: 10005257-200 To be used in conjunction with Cayman’s PGIS (mouse) Polyclonal Antibody (Item No. 100023) to block protein-antibody complex formation during immunochemical analysis of PGIS.
KGF (FGF-7), human, Reference: C-63820 Recombinant Human Keratinocyte Growth Factor (FGF-7; E. coli-derived)
Prostaglandin Transporter Blocking Peptide Reference: 10005388-200 Peptide Sequence: human PGT amino acids 6-20 (KLGVSQGSDTSTSRA) · To be used in conjunction with Cayman’s PGT polyclonal antibody (Item No. 160200) to block protein-antibody complex formation during immunochemical analysis of PGT.
KGF (FGF-7), human, Reference: C-63820A Recombinant Human Keratinocyte Growth Factor (FGF-7; plant-derived)
Doppel Blocking Peptide Reference: 10005516-200 Peptide Sequence: human doppel protein amino acids 112-120 (ATQAANQGE) · To be used in conjunction with Cayman’s Doppel polyclonal antibody (Catalog No. 10005517) to block protein-antibody complex formation during immunochemical analysis of Doppel protein.
KGF (FGF-7), human, Reference: C-63821 Recombinant Human Keratinocyte Growth Factor (FGF-7; HEK cell-derived)
IP Receptor (human) Blocking Peptide Reference: 10005519-200 Peptide Sequence: human IP receptor amino acids · To be used in conjunction with Cayman’s IP receptor (human) polyclonal antibody (Catalog No. 10005518) to block protein-antibody complex formation during immunochemical analysis for the IP receptor.